Glaukos Operating Income 2014-2024 | GKOS
Glaukos annual/quarterly operating income history and growth rate from 2014 to 2024. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
- Glaukos operating income for the quarter ending December 31, 2024 was $-0.029B, a 25.78% decline year-over-year.
- Glaukos operating income for the twelve months ending December 31, 2024 was $-0.122B, a 4.92% decline year-over-year.
- Glaukos annual operating income for 2024 was $-0.122B, a 4.92% decline from 2023.
- Glaukos annual operating income for 2023 was $-0.129B, a 56.35% increase from 2022.
- Glaukos annual operating income for 2022 was $-0.082B, a 150.4% increase from 2021.
| Glaukos Annual Operating Income (Millions of US $) |
|
|---|---|
| 2024 | $-122 |
| 2023 | $-129 |
| 2022 | $-82 |
| 2021 | $-33 |
| 2020 | $-124 |
| 2019 | $-50 |
| 2018 | $-13 |
| 2017 | $-2 |
| 2016 | $4 |
| 2015 | $-10 |
| 2014 | $-13 |
| 2013 | $-14 |
| Glaukos Quarterly Operating Income (Millions of US $) |
|
|---|---|
| 2024-12-31 | $-29 |
| 2024-09-30 | $-25 |
| 2024-06-30 | $-30 |
| 2024-03-31 | $-39 |
| 2023-12-31 | $-39 |
| 2023-09-30 | $-28 |
| 2023-06-30 | $-29 |
| 2023-03-31 | $-33 |
| 2022-12-31 | $-34 |
| 2022-09-30 | $-22 |
| 2022-06-30 | $-37 |
| 2022-03-31 | $10 |
| 2021-12-31 | $-18 |
| 2021-09-30 | $11 |
| 2021-06-30 | $-14 |
| 2021-03-31 | $-12 |
| 2020-12-31 | $-11 |
| 2020-09-30 | $-12 |
| 2020-06-30 | $-47 |
| 2020-03-31 | $-53 |
| 2019-12-31 | $-30 |
| 2019-09-30 | $-12 |
| 2019-06-30 | $-6 |
| 2019-03-31 | $-2 |
| 2018-12-31 | $2 |
| 2018-09-30 | $-7 |
| 2018-06-30 | $-4 |
| 2018-03-31 | $-4 |
| 2017-12-31 | $1 |
| 2017-09-30 | $1 |
| 2017-06-30 | $-4 |
| 2017-03-31 | $0 |
| 2016-12-31 | $0 |
| 2016-09-30 | $1 |
| 2016-06-30 | $2 |
| 2016-03-31 | $1 |
| 2015-12-31 | $-2 |
| 2015-09-30 | $-2 |
| 2015-06-30 | $-5 |
| 2015-03-31 | $-1 |
| 2014-12-31 | $-5 |
| 2014-09-30 | $-2 |
| 2014-06-30 | $-2 |
| 2014-03-31 | $-4 |
| 2013-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | MED INSTRUMENTS | $5.001B | $0.383B |
| Glaukos Corporation is an ophthalmic medical technology and pharmaceutical company. Glaukos is focused on the development and commercialization of novel surgical devices and sustained pharmaceutical therapies designed to treat glaucoma. Glaukos developed Micro Invasive Glaucoma Surgery to serve as an alternative to the traditional glaucoma treatment and management paradigms. The company's iStent platform is the first MIGS device in the United States. Glaukos markets its products through direct sales force in the United States and other countries. It has distribution partners in Europe, the Asia Pacific, Latin America, and internationally. | |||